Elythea is a machine learning (ML) platform to catch and prevent life-threatening complications of pregnancy in low-resource settings.
Team Leader
Reetam Ganguli
Elythea is an ML platform to catch and prevent life-threatening complications of pregnancy in low-resource settings
Solution Pitch
The Problem
Mothers in rural areas of low- and middle-income countries (LMICs) are more likely to die from missed medical complications. Prior access and knowledge to medical support can empower them to deliver in tertiary care hospitals, get prophylactic treatment, and allow care providers to prepare support like blood products in advance if they are at-risk for a complication like hemorrhaging.
The Solution
More than 80% of maternal mortalities are preventable with early intervention. Currently, doctors miss more than 50% of mothers who have life-threatening complications, and wait until labor to start doing manual risk assessments.
Elythea's proprietary ML models catch life-threatening obstetric complications (like postpartum hemorrhage, preeclampsia/eclampsia, emergency c-section, preterm labor, and more) as soon as the first visit. The program automatically analyzes relevant demographic and clinical risk factors, flags high-risk patients, and provides evidence-based interventions to prevent the complication altogether.
Elythea has completed prospective international clinical trials across the USA, Cameroon, and Nigeria demonstrating that its models have better performance than the current gold standard clinical methods.
Stats
1,000 lives directly impacted through clinical trials across Nigeria, Cameroon, Uganda, Ghana.
Market Opportunity
Preventable pregnancy complications in LMICs
Organization Highlights
Elythea has current partnerships with:
Medanjali: In process of signing contract to reach 100,000 rural moms and up to 1 million rural Indian patients by the end of 2024.
Maternal fetal medicine organization: letter of intent signed to reach >55,000 moms
North Carolina Clinic
Infiuss Health: Reaching 1,500 African mothers across three countries from randomized controlled trials
Partnership Goals
Elythea seeks introductions to anyone working at Medicaid managed care organizations (MCOs), state Medicaid programs, large commercial health plans, smaller community health plans, and value based care (VBC) hospital systems. They also seek assistance in working with government systems and hospitals in LMICs to improve risk scores for its mothers and help its providers intervene before life-threatening complications occur.
What is the name of your organization?
Elythea
What is the name of your solution?
Elythea
Provide a one-line summary or tagline for your solution.
Elythea is an ML platform to catch and prevent life-threatening complications of pregnancy in low-resource settings
In what city, town, or region is your solution team headquartered?
San Jose, CA
In what country is your solution team headquartered?
United States
What type of organization is your solution team?
For-Profit
Film your elevator pitch.
—
What specific problem are you solving?
African moms are more likely to die from missed medical complications. Prior access to medical support can empower them to deliver in tertiary care hospitals, get prophylactic treatment, and allow care providers to prepare support like blood products in advance if they are at-risk for a complication like hemorrhaging.
What is your solution?
More than 80% of maternal mortalities are preventable with early intervention. Currently, doctors miss more than 50% of mothers who have life-threatening complications, and wait until labor to start doing manual risk assessments. Elythea's proprietary ML models catch life-threatening obstetric complications (like postpartum hemorrhage, preeclampsia/eclampsia, emergency c-section, preterm labor, and more) as soon as the first visit. The program automatically analyzes relevant demographic and clinical risk factors, flags high-risk patients, and provides evidence-based interventions to prevent the complication altogether. Elythea has completed prospective international clinical trials across the USA, Cameroon, and Nigeria demonstrating that its models have better performance than the current gold standard clinical methods.
Who does your solution serve, and in what ways will the solution impact their lives?
We serve moms in developing countries and rural regions. Currently, these moms constitute 99% of the global maternal mortality.
Because they are unaware of their risk status, many high-risk moms ignore red-flag symptoms (that they have not been counseled to watch out for) because of the potential financial burden that traveling to the nearest hospital imposes. Many high-risk moms also go to their local community clinics expecting a normal pregnancy, and have precious hours wasted while they suffer through life-threatening complications like hemorrhaging or eclampsia as they are transported to a tertiary care facility.
Moms at risk of hypertensive disorders like eclampsia have defined prophylactic antihypertensive medication, exercise regimen, and diet modification, that they can undergo to drastically reduce their risk of their complication. In potentially‰ life-threatening cases, earlier induction of labor can be scheduled to optimize the likelihood of the mom and baby surviving. Currently, because doctors have poor accuracy in predicting these complications, these moms have to wait until they have their complications and must wait to be treated, risking death.
Elythea provides promise for these moms to live through their complications (and even prevent their complications in many cases).
Organization Type: For-profit, including B-Corp or similar models
